Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Diagnostics is a specialized manufacturer of high-purity chemicals and reagents for life science research, clinical diagnostics, and industrial applications. The company is particularly well-regarded for its innovations in electrophoresis, histology, and liquid scintillation, including the development of the Ecoscint line of biodegradable scintillation cocktails. Their product portfolio supports a wide range of laboratory techniques, including DNA and protein electrophoresis, tissue processing, and radioactive labeling. Headquartered in Atlanta, Georgia, the company has established a global presence through a network of international distributors. In 2021, National Diagnostics was acquired by Calibre Scientific, a global provider of life science products and services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Diagnostics.